Cargando…
Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy
BACKGROUND: Galectin-1, a radioresistance marker, was found in our previous study to be a prognostic factor for cervical cancer. The aim of current study is to determine the prognostic significance of the galectin-1 expression level in patients with glioblastoma multiforme (GBM) undergoing adjuvant...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789739/ https://www.ncbi.nlm.nih.gov/pubmed/29378529 http://dx.doi.org/10.1186/s12885-018-4025-2 |